A linear equation describing this relationship was established: equation(3) M=1.0322V+24.898since the target dose D (mg) is calculated as: equation(4) D=M.S/100D=M.S/100where M is the mass of the tablet and S is the percentage of loading filament. Therefore, the required dimension (L) to achieve a target dose (D) from filament with loading percentage (S) can be calculated as: equation(5) L=25100DS-24.8981.0322π3 A series of tablets were printed according to Eq. (5) to achieve a target dose of 2, 3, 4, 5, 7.5 or 10 mg. Table 1 illustrated the details of dimensions, expected and measured mass of these tablets. A MakerBot Replicator® 2X Experimental 3D Printer (MakerBot
Industries, New York, USA) was utilized to print blank PVA tablets. Blank tablets (PVA only) Ulixertinib were printed using default settings of the software for PLA filament as follows: type of printer: Replicator 2X; type of filament: PLA; resolution: Selleck BMS777607 standard; temperature of nozzle: 230 °C; temperature of building plate: 20 °C; speed of extruder 90 mm/s while extruding and 150 mm/s while traveling; infill: 100%; height of the layer: 200 μm. No supports or rafts were utilized in the printed model. In order to be able to print prednisolone loaded PVA tablets, the following modifications were implemented: (i) Kapton tape layer (default) provided poor adhesion of the designs to the built plate. Blue
Scotch painter’s tape was applied to the surface of the printing board to improve adhesion to the surface layer. In order to assess prednisolone content in drug loaded filaments and the printed tablets, each tablet (or 100 mg of filament) was accurately weighed and transferred to a 500 ml volumetric flask. Tablets were incubated for 1 h in 150 ml of distilled water under sonication followed by completing the volume with methanol to 500 ml, and subsequent sonication for an additional 4 h at 50 °C. After cooling to room temperature, samples were filtered through a 0.22 μm Millex-GP syringe filter (Merck Millipore, USA) and prepared
found for HPLC analysis. Prednisolone concentration was determined through HPLC analysis method using an Agilent HPLC 1260 series (Agilent Technologies, Inc., Germany) equipped with Kinetex C18 column (100 × 2.1 mm, particle size 2.6 μm) (Phenomenex, Torrance, USA). The mobile phase (water: acetonitrile) was used in gradient concentrations: (60:40 at time 0, 40:60 at time 8–12 min and 60:40 at time 12.01–14 min) at a flow rate of 0.5 ml/min. The injection volume was set at 40 μl and the UV detector employed an absorbance wavelength of 250 nm. Temperature of the column was maintained at 45 °C and stop time for each sample was 14 min. The surface morphology of the PVA filament, extruded filament from the nozzle of the 3D printer as well as the printed tablet was assessed using a Quanta-200 SEM microscope at 20 kV.